Steward Partners Investment Advisory, LLC Trevena Inc Transaction History

Steward Partners Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$0.57 - $1.29 $6,269 - $14,190	-11,000 Reduced 84.62%	2,000 $1,000
Q3 2021 Nov 12, 2021	SELL	$1.11 - $1.7 $1,110 - $1,700	-1,000 Reduced 7.14%	13,000 $16,000
Q1 2021 May 14, 2021	SELL	$1.77 - $2.93 $1,770 - $2,930	-1,000 Reduced 6.67%	14,000 $25,000
Q4 2020 Feb 11, 2021	SELL	$2.13 - $3.26 $6,390 - $9,780	-3,000 Reduced 16.67%	15,000 $32,000
Q3 2020 Oct 30, 2020	BUY	$1.53 - $3.13 $24,480 - $50,080	16,000 Added 800.0%	18,000 $54,000
Q2 2020 Aug 06, 2020	BUY	$0.48 - $1.75 $960 - $3,500	2,000 New	2,000 $3,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $313M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.